BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16540065)

  • 1. Treatment of pemphigus vulgaris. An overview in Mexico.
    Tirado-Sánchez A; León-Dorantes G
    Allergol Immunopathol (Madr); 2006; 34(1):10-6. PubMed ID: 16540065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pemphigus: current therapy.
    Rosenkrantz WS
    Vet Dermatol; 2004 Apr; 15(2):90-8. PubMed ID: 15030557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of pemphigus.
    Tsuruta D; Ishii N; Hashimoto T
    Immunotherapy; 2012 Jul; 4(7):735-45. PubMed ID: 22853759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pemphigus: a review].
    Joly P; Sin C
    Ann Dermatol Venereol; 2011 Mar; 138(3):182-200. PubMed ID: 21397148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapy of pemphigus.
    Bystryn JC
    Arch Dermatol; 1984 Jul; 120(7):941-51. PubMed ID: 6375579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recalcitrant pemphigus vulgaris responding to systemic tacrolimus.
    Büsing V; Kern JS; Bruckner-Tuderman L; Hofmann SC
    Dermatology; 2010; 221(2):122-6. PubMed ID: 20587990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil.
    Biot Sdel R; Franco JP; Lima RB; Pereira HN; Marques LP; Martins CJ
    An Bras Dermatol; 2014; 89(6):980-4. PubMed ID: 25387507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
    Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
    Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus on the treatment of autoimmune bullous dermatoses: pemphigus vulgaris and pemphigus foliaceus - Brazilian Society of Dermatology.
    Porro AM; Hans Filho G; Santi CG
    An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):20-32. PubMed ID: 31166407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
    Koga H; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Hashimoto T
    Eur J Dermatol; 2010; 20(4):472-5. PubMed ID: 20406724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pemphigus vulgaris. Clinical aspects, pathophysiology and therapy of a bullous autoimmune dermatosis].
    Sunderkötter CH; Luger TA
    Med Monatsschr Pharm; 1995 Sep; 18(9):255-63. PubMed ID: 7476660
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of the immunobullous disorders. II. Pemphigus.
    Huilgol SC; Black MM
    Clin Exp Dermatol; 1995 Jul; 20(4):283-93. PubMed ID: 8548984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pemphigus: current and future treatment strategies].
    Kussini J; Kaisers T; Sequeira Santos AM; Eming R; Didona D
    Dermatologie (Heidelb); 2022 Dec; 74(12):915-926. PubMed ID: 37902884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pemphigus vulgaris: update on etiopathogenesis, oral manifestations, and management.
    Scully C; Challacombe SJ
    Crit Rev Oral Biol Med; 2002; 13(5):397-408. PubMed ID: 12393759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based treatments in pemphigus vulgaris and pemphigus foliaceus.
    Frew JW; Martin LK; Murrell DF
    Dermatol Clin; 2011 Oct; 29(4):599-606. PubMed ID: 21925004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pemphigus: associations and management guidelines: facts and controversies.
    Ruocco E; Wolf R; Ruocco V; Brunetti G; Romano F; Lo Schiavo A
    Clin Dermatol; 2013; 31(4):382-390. PubMed ID: 23806155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Unexpected positive outcome following rituximab treatment in a patient with pemphigus vegetans resistant to conventional therapies: a case report].
    Barbach Y; Baybay H; Mrabat S; Chaouche M; Elloudi S; Mernissi FZ
    Pan Afr Med J; 2019; 32():101. PubMed ID: 31223391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate is effective in the treatment of pemphigus vulgaris.
    Enk AH; Knop J
    Arch Dermatol; 1999 Jan; 135(1):54-6. PubMed ID: 9923781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of pemphigus vulgaris: current and emerging options.
    Yeh SW; Sami N; Ahmed RA
    Am J Clin Dermatol; 2005; 6(5):327-42. PubMed ID: 16252932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment failure with rituximab in a patient with pemphigus vulgaris.
    Weger W; Aberer E
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):387-9. PubMed ID: 18269618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.